X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2866952/0/en/Oculis-Announces-Closing-of-Registered-Direct-Offering-and-Commencement-of-Trading-on-Nasdaq-Iceland-Main-Market.html
https://www.globenewswire.com/news-release/2024/04/11/2861510/0/en/Oculis-Announces-Completion-of-Oversubscribed-59-Million-Registered-Direct-Offering-and-Subsequent-Listing-on-Nasdaq-Iceland-Main-Market.html
https://www.globenewswire.com/news-release/2024/04/10/2860586/0/en/Oculis-Strengthens-its-Executive-Leadership-Team-with-the-Appointment-of-Snehal-Shah-Pharm-D-as-President-of-Research-Development.html
https://www.globenewswire.com/news-release/2024/04/04/2857603/0/en/Oculis-to-Participate-at-Upcoming-April-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/03/18/2847628/0/en/Oculis-Reports-Q4-and-Full-Year-2023-Financial-Results-and-Update-on-Company-Progress.html
https://www.globenewswire.com//news-release/2024/02/28/2836750/0/en/Oculis-Provides-Updates-at-R-D-Day-on-Late-Stage-Clinical-Trials-and-Announces-Key-Leadership-Appointments.html
https://www.globenewswire.com/news-release/2024/01/29/2818662/0/en/Oculis-to-Present-at-Upcoming-February-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/22/2812869/0/en/Oculis-to-Host-In-Person-Virtual-R-D-Day-in-New-York-on-February-28-2024.html
https://www.globenewswire.com//news-release/2023/12/20/2799127/0/en/Oculis-Announces-First-Patient-First-Visit-in-Phase-3-OPTIMIZE-2-Trial-of-OCS-01-for-the-Treatment-of-Inflammation-and-Pain-Following-Cataract-Surgery.html
https://www.globenewswire.com//news-release/2023/12/18/2797627/0/en/Oculis-Announces-First-Patient-First-Visit-in-Phase-3-DIAMOND-1-Trial-of-OCS-01-Eye-Drop-in-Diabetic-Macular-Edema.html
Market Place
Share 
